C[C@@H]1NC(=O)[C@@]2(C)[C@@H](c3ccccc3)[C@H]3COc4ccc(Cl)cc4[C@@H]3N2C1=O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?